Greece is last on a list of 11 countries offering full or limited access to advanced drug treatments, a pharma study reveals.

While the multinationals’ top executives are expected to discuss global sector issues, the Greek side, as host of the morning meeting, is interested in promoting the country as an investment and R&D destination.

An aging population and economic constraints contribute to a strained Greek National Healthcare System (ESY), appearing insufficient in meeting the demands of the times